The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

Nature Medicine

Volumn 6, Issue 6, 2000, Pages 637-641

  Conne, Béatrice ^a,b   Stutz, André ^a   Vassalli, Jean Dominique ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CMU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

GENE EXPRESSION REGULATION; HUMAN; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA STRUCTURE; RNA TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; TRANSLATION REGULATION; UNTRANSLATED REGION;

3' UNTRANSLATED REGIONS; ANIMALS; HUMANS; MYOTONIC DYSTROPHY; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY;

EID: 0034101197     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/76211     Document Type: Review

References (38)

1. Stebbins-Boaz, B. & Richter, J.D. Translational control during early development. Crit. Rev. Eukaryot. Gene Expr. 7, 73-94 (1997).
2. Gao, F.B. Messenger RNAs in dendrites: localization, stability, and implications for neuronal function. Bioessays 20, 70-8 (1998).
3. Richter, J.D. Cytoplasmic polyadenylation in development and beyond. Microbiol. Mol. Biol. Rev. 63, 446-56 (1999).
4. Stutz, A. et al. In vivo antisense oligodeoxynucleotide mapping reveals masked regulatory elements in an mRNA dormant in mouse oocytes. Mol. Cell. Biol. 17, 1759-1767 (1997).
5. Stutz, A. et al. Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes. Genes Dev. 12, 2535-2548 (1998).
6. Korade-Mirnics, Z., Babitzke, P. & Hoffman, E. Myotonic dystrophy: molecular windows on a complex etiology. Nucleic Acids Res. 26, 1363-1368 (1998).
7. Timchenko, L.T. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am. J. Hum. Genet. 64, 360-364 (1999).
8. Groenen, P.J. et al. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. Hum. Mol. Genet. 9, 605-616 (2000).
9. Storbeck, C.J., Sabourin, L.A., Waring, J.D. & Korneluk, R.G. Definition of regulatory sequence elements in the promoter region and the first intron of the myotonic dystrophy protein kinase gene. J. Biol. Chem. 273, 9139-9147 (1998).
10. Strong, P.N. & Brewster, B.S. Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive. J. Inherit. Metab. Dis. 20, 159-170 (1997).
11. Reddy, S. et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet. 13, 325-335 (1996).
12. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. & Housman, D.E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94, 7388-7393 (1997).
13. Lu, X., Timchenko, N.A. & Timchenko, L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8, 53-60 (1999).
14. Roberts, R. et al. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94, 13221-13226 (1997).
15. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. & Singer, R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995-1002 (1995).
16. Philips, A.V., Timchenko, L.T. & Cooper, T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737-741 (1998).
17. Timchenko, N.A., Welm, A.L., Lu, X. & Timchenko, L.T. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms. Nucleic Acids Res. 27, 4517-4525 (1999).
18. Sasagawa, N., Takahashi, N., Suzuki, K. & Ishiura, S. An expanded CTG trinucleotide repeat causes trans RNA interference: a new hypothesis for the pathogenesis of myotonic dystrophy. Biochem. Biophys. Res. Commun. 264, 76-80 (1999).
19. Boucher, C.A. et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum. Mol. Genet. 4, 1919-1925 (1995).
20. Thornton, C.A., Wymer, J.P., Simmons, Z., McClain, C. & Moxley, R.T.3rd. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet. 16, 407-409 (1997).
21. Klesert, T.R., Otten, A.D., Bird, T.D. & Tapscott, S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet. 16, 402-406 (1997).
22. Eriksson, M., Ansved, T., Edstrom, L., Anvret, M. & Carey, N. Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: the CTG expansion correlates inversely with DMPK and 59 expression levels, but notDMAHP levels. Hum. Mol. Genet. 8, 1053-1060 (1999).
23. Chen, C.Y. & Shyu, A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470 (1995).
24. Peng, S.S., Chen, C.Y., Xu, N. & Shyu, A.B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17, 3461-3470 (1998).
25. Rimokh, R. et al. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83, 3689-3696 (1994).
26. Chagnovich, D., Fayos, B.E. & Cohn, S.L. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma. J. Biol. Chem. 271, 33587-33591 (1996).
27. Chagnovich, D. & Cohn, S.L. Binding of a 40-kDa protein to the N-myc 3′-untranslated region correlates with enhanced N-myc expression in human neuroblastoma. J. Biol. Chem. 271, 33580-33586 (1996).
28. Chagnovich, D. & Cohn, S.L. Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma. Eur. J. Cancer 33, 2064-2067 (1997).
29. Lai, W.S. et al. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell Biol. 19, 4311-4323 (1999).
30. Carballo, E., Lai, W.S. & Blackshear, P.J. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281, 1001-1005 (1998).
31. Carballo, E., Lai, W.S. & Blackshear, P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95, 1891-1899 (2000).
32. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398 (1999).
33. Weiss, I.M. & Liebhaber, S.A. Erythroid cell-specific mRNA stability elements in the α2-globin 3′ nontranslated region. Mol. Cell Biol. 15, 2457-2465 (1995).
34. Wang, X., Kiledjian, M., Weiss, I.M. & Liebhaber, S.A. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol Cell Biol 15, 1769-1777 (1995); erratum: 15, 2331 (1995).
35. Morales, J., Russell, J.E. & Liebhaber, S.A. Destabilization of human alpha-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J. Biol. Chem. 272, 6607-6613 (1997).
36. Russell, J.E. & Liebhaber, S.A. The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3′ untranslated region. Blood 87, 5314-5323 (1996).
37. Kobayashi, K. et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392 (1998).
38. Fu, L., Minden, M.D. & Benchimol, S. Translational regulation of human p53 gene expression. EMBO J. 15, 4392-4401 (1996).